Melatonin versus chloral hydrate on sleep induction for recording electroencephalography in children: a randomized

Insights

Melatonin and chloral hydrate are effective for pediatric EEG sedation. Melatonin offers faster recovery and fewer side effects than chloral hydrate for pediatric electroencephalography (EEG) sleep induction.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Diagnostic Imaging

Background:

  • Electroencephalography (EEG) is crucial for diagnosing pediatric seizures.
  • Current EEG protocols often involve partial sleep deprivation and sedative medications.
  • Evaluating alternative sedatives for improved pediatric EEG procedures is necessary.

Purpose of the Study:

  • To compare the efficacy of melatonin versus chloral hydrate for sleep induction in pediatric EEG recordings.
  • To assess sedation onset, duration, recovery time, and side effects of both agents.
  • To determine the impact of these sedatives on the detection of epileptiform waves in pediatric EEGs.

Main Methods:

  • A parallel-blinded randomized clinical trial involving 78 children aged 6 months to 5 years.
  • Participants were randomized to receive either melatonin (0.4 mg/kg) or chloral hydrate (0.5 ml/kg).
  • Key outcomes included sedation start and duration, recovery time, adverse events, and EEG findings, analyzed using SPSS (significance P<0.05).

Main Results:

  • Both melatonin (92%) and chloral hydrate (95%) showed high success rates in sedation induction (P=0.5).
  • Sedation onset and duration were comparable between the two groups (P>0.1).
  • Melatonin demonstrated significantly shorter recovery times (P<0.001) and a lower incidence of mild side effects (P=0.013) compared to chloral hydrate.

Conclusions:

  • Melatonin is as effective as chloral hydrate for inducing sedation in pediatric EEG.
  • Melatonin offers advantages of faster recovery and a better safety profile.
  • These findings support melatonin as a favorable alternative for pediatric EEG procedures.
Abstract

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
259
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
182
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
408